Hoyer D, Pazos A, Probst A, Palacios J M
Brain Res. 1986 Jun 18;376(1):85-96. doi: 10.1016/0006-8993(86)90902-9.
The presence, pharmacological properties and anatomical distribution of serotonin-1A and serotonin-1B receptor subtypes were studied in the human brain by both radioligand binding assays and autoradiographic procedures. Frontal cortices and hippocampi from human brains obtained at autopsy without evidence of neurological disease were used in this study. [3H]5-HT was used to label both 5-HT1A and 5-HT1B receptor subtypes. 5-HT1A receptors were selectively labeled by [3H]8-hydroxy-2[di-N-propylamino]tetralin, while 5-HT1B receptors were labeled by (-)-[125I]iodocyanopindolol ([125I]CYP) in the presence of 30 microM isoprenaline. The pharmacological profile of 5-HT1A receptors in human brain tissue was very similar to those previously found in rat and pig brain tissues. The general anatomical distribution of these sites was also similar to that found in the rat brain, although some differences were observed when analyzed at the microscopic level. In contrast to 5-HT1A receptors, it was not possible to identify 5-HT receptors having the pharmacological properties of 5-HT1B sites in the human brain, using either [3H]5-HT or [125I]CYP as ligands. The absence of identifiable 5-HT1B receptors in human brain preparations, a fact previously found in pig brain tissue, is discussed in terms of the existence of species differences in brain serotonin receptors.
通过放射性配体结合试验和放射自显影程序,对人脑中5-羟色胺-1A和5-羟色胺-1B受体亚型的存在、药理学特性及解剖分布进行了研究。本研究使用了取自尸检时无神经疾病证据的人脑额叶皮质和海马体。[3H]5-羟色胺用于标记5-HT1A和5-HT1B受体亚型。5-HT1A受体用[3H]8-羟基-2-[二-N-丙基氨基]四氢萘选择性标记,而5-HT1B受体在存在30微摩尔异丙肾上腺素的情况下用(-)-[125I]碘氰吲哚洛尔([125I]CYP)标记。人脑组织中5-HT1A受体的药理学特征与先前在大鼠和猪脑组织中发现的非常相似。这些位点的总体解剖分布也与大鼠脑中的相似,尽管在微观水平分析时观察到了一些差异。与5-HT1A受体相反,使用[3H]5-羟色胺或[125I]CYP作为配体,无法在人脑中鉴定出具有5-HT1B位点药理学特性的5-羟色胺受体。人脑制剂中缺乏可识别的5-HT1B受体这一事实(先前在猪脑组织中也发现过),根据脑5-羟色胺受体存在种属差异进行了讨论。